| 000 | 01722 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518003839.0 | ||
| 264 | 0 | _c20190911 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/s41416-018-0274-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodgson, Darren R | |
| 245 | 0 | 0 |
_aCandidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _c11 2018 |
||
| 300 |
_a1401-1409 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xtherapeutic use |
| 700 | 1 | _aDougherty, Brian A | |
| 700 | 1 | _aLai, Zhongwu | |
| 700 | 1 | _aFielding, Anitra | |
| 700 | 1 | _aGrinsted, Lynda | |
| 700 | 1 | _aSpencer, Stuart | |
| 700 | 1 | _aO'Connor, Mark J | |
| 700 | 1 | _aHo, Tony W | |
| 700 | 1 | _aRobertson, Jane D | |
| 700 | 1 | _aLanchbury, Jerry S | |
| 700 | 1 | _aTimms, Kirsten M | |
| 700 | 1 | _aGutin, Alexander | |
| 700 | 1 | _aOrr, Maria | |
| 700 | 1 | _aJones, Helen | |
| 700 | 1 | _aGilks, Blake | |
| 700 | 1 | _aWomack, Chris | |
| 700 | 1 | _aGourley, Charlie | |
| 700 | 1 | _aLedermann, Jonathan | |
| 700 | 1 | _aBarrett, J Carl | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 119 _gno. 11 _gp. 1401-1409 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41416-018-0274-8 _zAvailable from publisher's website |
| 999 |
_c28970461 _d28970461 |
||